scispace - formally typeset
N

Nina Aass

Researcher at Oslo University Hospital

Publications -  124
Citations -  8539

Nina Aass is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Testicular cancer & Palliative care. The author has an hindex of 48, co-authored 113 publications receiving 7622 citations. Previous affiliations of Nina Aass include Norwegian University of Science and Technology & Medical Research Council.

Papers
More filters
Journal ArticleDOI

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial

TL;DR: This trial has shown the non-inferiority of carboplatin to radiotherapy in the treatment of stage I seminoma, although the absence of disease-related deaths and preliminary data indicating fewer second primary testicular germ-cell tumours favourcarboplatin use, these findings need to be confirmed beyond 4 years' follow-up.
Journal ArticleDOI

Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study

TL;DR: Treatment with infradiaphragmatic RT and/or cisplatin-based chemotherapy, particularly the BEP regimen, increases the long-term risk for CVD in survivors of TC.
Journal ArticleDOI

Anxiety and depression in cancer patients: relation between the Hospital Anxiety and Depression Scale and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire

TL;DR: The EF dimension of EORTC QLQ C33 predominantly assesses anxiety, whereas depression is rated to a lesser degree, which implies a risk of underdiagnosed depression, if the EOR TC QLq C33 is used as the only instrument to screen for psychological distress in cancer patients.
Journal ArticleDOI

Prevalence and Aetiology of Neuropathic Pain in Cancer Patients: A Systematic Review

TL;DR: The prevalence of neuropathic mechanisms in patients with cancer pain was identified to highlight the need for detailed assessment and to support the development of an international classification system for cancer pain.